APA

Hamedani N. S., Rühl H., Zimmermann J. J., Heiseler T., Oldenburg J., Mayer G., Pötzsch B. & Müller J. (20171110). In Vitro Evaluation of Aptamer-Based Reversible Inhibition of Anticoagulant Activated Protein C as a Novel Supportive Hemostatic Approach. : Nucleic acid therapeutics.

Chicago

Hamedani Nasim Shahidi, Rühl Heiko, Zimmermann Julia Janina, Heiseler Tim, Oldenburg Johannes, Mayer Günter, Pötzsch Bernd and Müller Jens. 20171110. In Vitro Evaluation of Aptamer-Based Reversible Inhibition of Anticoagulant Activated Protein C as a Novel Supportive Hemostatic Approach. : Nucleic acid therapeutics.

Harvard

Hamedani N. S., Rühl H., Zimmermann J. J., Heiseler T., Oldenburg J., Mayer G., Pötzsch B. and Müller J. (20171110). In Vitro Evaluation of Aptamer-Based Reversible Inhibition of Anticoagulant Activated Protein C as a Novel Supportive Hemostatic Approach. : Nucleic acid therapeutics.

MLA

Hamedani Nasim Shahidi, Rühl Heiko, Zimmermann Julia Janina, Heiseler Tim, Oldenburg Johannes, Mayer Günter, Pötzsch Bernd and Müller Jens. In Vitro Evaluation of Aptamer-Based Reversible Inhibition of Anticoagulant Activated Protein C as a Novel Supportive Hemostatic Approach. : Nucleic acid therapeutics. 20171110.